Clinical trial to evaluate the efficacy and safety of investigational product in treating non-healing foot ulcers in subjects with diabetes mellitus

  • STATUS
    Recruiting
Updated on 25 March 2021

Summary

Clinical trial to evaluate the efficacy and safety of investigational product in treating non-healing foot ulcers in subjects with diabetes mellitus

Description

Clinical trial to evaluate the efficacy and safety of investigational product in treating non-healing foot ulcers in subjects with diabetes mellitus

Length of Subject enrollment: total of 24 weeks
$75 per visit for time and travel. May be compensated up to $1,500

Details
Condition Diabetic Foot Ulcers, Diabetes Mellitus Types I and II
Clinical Study IdentifierTX138783
Last Modified on25 March 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients diagnosed with Type I or Type 2 Diabetes with at least one chronic (present for at least one month and no more than 10 months), non-healing plantar neuropathic foot ulcer of 0.75 - 6.0cm on the midfoot or forefoot
Male or female 18 years or older
Diabetes T1 or T2 with HbA1c of <12% and a serum creatinine level of <3mg/dl
Comply with study procedures
At screening, at least one chronic non-healing target ulcer
Non healing as defined as <30% reduction in size in response to standard of care during the screening period
Partial-or-full skin thickness not involving bone, tendon, or capsule
No sign of infection or osteomyelitis
Whole ulcer predominantly on the plantar surface of the foot
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note